Profiling of Blood Immune Biomarkers in Bladder Cancer
About this study
The purpose of this study is to characterize the immune markers of granulocytes, lymphocytes and monocytes in peripheral blood of newly diagnosed bladder cancer patients.
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.See eligibility criteria
- Male and female 19 to 85 years with urothelial bladder cancer
- Age 18 and under
- Pregnant women
- Mental abnormalities
Participating Mayo Clinic locations
Study statuses change often. Please contact us for help.
|Mayo Clinic Location
Mayo Clinic principal investigator
John Cheville, M.D.
Closed for enrollment
John Cheville M.D.